HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antithrombotic effects of saratin on human atherosclerotic plaques.

Abstract
Platelets play a primary role in thrombus formation after plaque rupture. Platelets recognize the exposed collagen via Von Willebrand factor (VWF) and become activated. Saratin, an inhibitor of the VWF-dependent binding of platelets to collagen, may reduce the thrombotic risk associated to atherosclerosis. Our objective was to evaluate the antithrombotic effects of local treatment with saratin on human atherosclerotic lesions. Thrombus formation was assessed by the deposition of (111)In-platelets on different human atherosclerotic lesions under three local shear conditions (800,1700 and 3400/s) with blood derived from catheterized pigs. Human atherosclerotic lesions were locally treated with saratin (30 microg/ml) at 37 degrees C for 5 min and placed in the chamber. Under stenotic shear conditions of 800/s, saratin significantly (p<0.05) reduced platelet deposition triggered by human denuded vessel wall (44%), fatty streaks (47%), severely damaged vessel (50%) and atherosclerotic plaque (57%). Thrombus characterization by immunohistochemistry showed also a reduction in fibrin deposition in treat-ed vessels. These results suggest that the local site-specific treatment with saratin inhibits atherosclerotic plaque thrombogenicity at haemodynamic conditions typical of moderately stenotic coronary arteries.
AuthorsGemma Vilahur, Xavier Duran, Oriol Juan-Babot, Laura Casaní, Lina Badimon
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 92 Issue 1 Pg. 191-200 (Jul 2004) ISSN: 0340-6245 [Print] Germany
PMID15213861 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fibrinolytic Agents
  • Indium Radioisotopes
  • Salivary Proteins and Peptides
  • saratin
  • von Willebrand Factor
  • Collagen
Topics
  • Animals
  • Arteriosclerosis (complications, drug therapy, pathology)
  • Blood Platelets (drug effects)
  • Collagen (pharmacology)
  • Fibrinolytic Agents (pharmacology)
  • Humans
  • In Vitro Techniques
  • Indium Radioisotopes
  • Platelet Adhesiveness (drug effects)
  • Salivary Proteins and Peptides (pharmacology)
  • Sus scrofa
  • Thrombosis (etiology, prevention & control)
  • von Willebrand Factor (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: